RAINBOW - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.2
| Stock Code | RAINBOW | Market Cap | 11,214 Cr. | Current Price | 1,104 ₹ | High / Low | 1,646 ₹ |
| Stock P/E | 45.7 | Book Value | 156 ₹ | Dividend Yield | 0.27 % | ROCE | 18.3 % |
| ROE | 16.7 % | Face Value | 10.0 ₹ | DMA 50 | 1,202 ₹ | DMA 200 | 1,313 ₹ |
| Chg in FII Hold | -2.61 % | Chg in DII Hold | 2.03 % | PAT Qtr | 65.8 Cr. | PAT Prev Qtr | 73.2 Cr. |
| RSI | 32.1 | MACD | -21.9 | Volume | 2,37,650 | Avg Vol 1Wk | 1,73,110 |
| Low price | 1,009 ₹ | High price | 1,646 ₹ | PEG Ratio | 2.57 | Debt to equity | 0.46 |
| 52w Index | 14.9 % | Qtr Profit Var | -1.73 % | EPS | 24.2 ₹ | Industry PE | 43.5 |
📊 Rainbow Children’s Medicare shows decent fundamentals but weak technical indicators, making it a cautious candidate for swing trading. The RSI at 32.1 indicates oversold conditions, while MACD (-21.9) confirms bearish momentum. The stock is trading below both its 50 DMA (1,202 ₹) and 200 DMA (1,313 ₹), signaling short-term weakness. Valuation is stretched with a P/E of 45.7 compared to industry average of 43.5, though strong ROCE (18.3%) and ROE (16.7%) provide support.
💡 Optimal Entry Price: Around 1,080–1,100 ₹ (near current support)
💡 Exit Strategy (if already holding): Consider exiting near 1,200–1,220 ₹ (50 DMA resistance) unless momentum strengthens.
🌟 Positive
- Strong ROCE (18.3%) and ROE (16.7%) indicate efficient capital use.
- Debt-to-equity ratio of 0.46 is moderate and manageable.
- EPS of 24.2 ₹ supports earnings consistency.
- DII holdings increased (+2.03%), showing domestic investor confidence.
⚠️ Limitation
- P/E ratio (45.7) higher than industry average (43.5), suggesting overvaluation.
- Dividend yield of 0.27% is very low.
- PEG ratio of 2.57 indicates limited growth relative to valuation.
- Stock trading below both 50 DMA and 200 DMA.
📉 Company Negative News
- Bearish technical indicators: RSI oversold and MACD negative.
- Quarterly PAT declined (65.8 Cr. vs 73.2 Cr.).
- FII holdings decreased (-2.61%), showing reduced foreign confidence.
📈 Company Positive News
- Strong ROCE and ROE metrics support operational efficiency.
- Domestic institutional investors increasing holdings significantly.
- EPS of 24.2 ₹ reflects stable earnings power.
🏭 Industry
- Industry P/E at 43.5, while Rainbow trades slightly higher at 45.7.
- Healthcare sector benefits from rising demand for specialized medical services in India.
- Competition remains strong, requiring consistent service quality and expansion.
✅ Conclusion
Rainbow Children’s Medicare is fundamentally stable but technically weak, making it a cautious swing trade candidate. Entry near 1,080–1,100 ₹ is favorable, with an exit target around 1,200–1,220 ₹. Traders should remain cautious due to oversold conditions and weak momentum, while long-term investors may hold for sectoral growth potential supported by strong efficiency metrics and domestic investor confidence.